Tudor Investment Corp
PCVX icon

Tudor Investment Corp’s Vaxcyte PCVX Stock Holding History

Tudor Investment Corp’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-73,035
Closed -$2.63M – 3918
2025
Q3 		$2.63M Buy
73,035
+19,953
+38% +$661K ﹤0.01% 1632
2025
Q2 		$1.73M Buy
+53,082
New +$1.74M ﹤0.01% 1757
2023
Q3 		– Sell
-31,068
Closed -$1.55M – 2723
2023
Q2 		$1.55M Sell
31,068
-6,793
-18% -$322K 0.02% 1042
2023
Q1 		$1.42M Buy
+37,861
New +$1.61M 0.02% 979

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's PCVX Position: Q4 2025 in Review

Tudor Investment Corp sold out of Vaxcyte (PCVX) in Q4 2025, closing a stake of 73,035 shares — an estimated $2.63M sold.

Tudor Investment Corp first reported a position in PCVX in Q1 2023 and held it in 4 quarters. The position peaked at $2.63M in Q3 2025. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

  • Tudor Investment Corp reported no remaining Vaxcyte position as of Q4 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 73,035 Vaxcyte shares in Q4 2025, an estimated $2.63M.
  • Tudor Investment Corp first reported a position in Vaxcyte in Q1 2023 and held it in 4 quarters.
  • Tudor Investment Corp's Vaxcyte position peaked at $2.63M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.